Chemomab Therapeutics regains compliance with Nasdaq

• Chemomab Therapeutics (NASDAQ:CMMB) said it received a notification letter from the Nasdaq stating that the company has regained compliance with the minimum bid price requirement.
• Press Release 

More on Chemomab Therapeutics

• Chemomab falls on private placement despite mid-stage win for lead asset
• Seeking Alpha’s Quant Rating on Chemomab Therapeutics